Stay updated on Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for a Phase II study of sEphB4-HSA plus pembrolizumab in solid tumors is available again, with study details, participant criteria, locations, and outcome measures.
    Difference
    60%
    Check dated 2026-11-07T14:46:34.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The site revision identifier changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T15:41:42.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition. It appears above the ClinicalTrials.gov access-error page.
    Difference
    1%
    Check dated 2026-10-24T14:48:49.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page. Its footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:34:16.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T14:41:55.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page instead of the study record content, with the usual header and footer intact.
    Difference
    20%
    Check dated 2026-09-19T21:51:12.000Z thumbnail image

Stay in the know with updates to Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab Clinical Trial page.